BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12604234)

  • 21. A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinity.
    Qiu W; Campbell RL; Gangloff A; Dupuis P; Boivin RP; Tremblay MR; Poirier D; Lin SX
    FASEB J; 2002 Nov; 16(13):1829-31. PubMed ID: 12223444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning of equine 17beta-hydroxysteroid dehydrogenase type 1 and its downregulation during follicular luteinization in vivo.
    Brown KA; Sayasith K; Bouchard N; Lussier JG; Sirois J
    J Mol Endocrinol; 2007 Feb; 38(1-2):67-78. PubMed ID: 17242170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substituted 6-phenyl-2-naphthols. Potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1): design, synthesis, biological evaluation, and pharmacokinetics.
    Marchais-Oberwinkler S; Kruchten P; Frotscher M; Ziegler E; Neugebauer A; Bhoga U; Bey E; Müller-Vieira U; Messinger J; Thole H; Hartmann RW
    J Med Chem; 2008 Aug; 51(15):4685-98. PubMed ID: 18630892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.
    Gangloff A; Garneau A; Huang YW; Yang F; Lin SX
    Biochem J; 2001 May; 356(Pt 1):269-76. PubMed ID: 11336660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1.
    Li T; Song X; Stephen P; Yin H; Lin SX
    J Steroid Biochem Mol Biol; 2023 Apr; 228():106246. PubMed ID: 36634828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.
    Frotscher M; Ziegler E; Marchais-Oberwinkler S; Kruchten P; Neugebauer A; Fetzer L; Scherer C; Müller-Vieira U; Messinger J; Thole H; Hartmann RW
    J Med Chem; 2008 Apr; 51(7):2158-69. PubMed ID: 18324762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4.
    Yu Y; Deck JA; Hunsaker LA; Deck LM; Royer RE; Goldberg E; Vander Jagt DL
    Biochem Pharmacol; 2001 Jul; 62(1):81-9. PubMed ID: 11377399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum.
    Gomez MS; Piper RC; Hunsaker LA; Royer RE; Deck LM; Makler MT; Vander Jagt DL
    Mol Biochem Parasitol; 1997 Dec; 90(1):235-46. PubMed ID: 9497046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactivation of human placental 17 beta,20 alpha-hydroxysteroid dehydrogenase affinity alkylated by estrone 3-(bromoacetate): topographic studies with 16 alpha-(bromoacetoxy)estradiol 3-(methyl ether).
    Thomas JL; LaRochelle MC; Asibey-Berko E; Strickler RC
    Biochemistry; 1985 Sep; 24(20):5361-7. PubMed ID: 3865689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.
    Möller G; Deluca D; Gege C; Rosinus A; Kowalik D; Peters O; Droescher P; Elger W; Adamski J; Hillisch A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6740-4. PubMed ID: 19836949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalysed by a human placental 17beta-hydroxysteroid dehydrogenase.
    Jarabak R; Harvey RG; Jarabak J
    Arch Biochem Biophys; 1996 Mar; 327(1):174-80. PubMed ID: 8615688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focused libraries of 16-substituted estrone derivatives and modified e-ring steroids: inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
    Vicker N; Lawrence HR; Allan GM; Bubert C; Smith A; Tutill HJ; Purohit A; Day JM; Mahon MF; Reed MJ; Potter BV
    ChemMedChem; 2006 Apr; 1(4):464-81. PubMed ID: 16892382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The derivation of a potential transition state for the reduction reaction catalysed by 17beta-hydroxysteroid dehydrogenase--an approximate representation of its active site for use in drug design and discovery.
    Owen CP; Ahmed S
    Biochem Biophys Res Commun; 2004 May; 318(1):131-4. PubMed ID: 15110763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary deoxyribonucleic acid cloning and enzymatic characterization of a novel 17beta/3alpha-hydroxysteroid/retinoid short chain dehydrogenase/reductase.
    Su J; Lin M; Napoli JL
    Endocrinology; 1999 Nov; 140(11):5275-84. PubMed ID: 10537158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of hamster NAD+-dependent 3(17)β-hydroxysteroid dehydrogenase belonging to the aldo-keto reductase 1C subfamily.
    Endo S; Noda M; Ikari A; Tatematsu K; El-Kabbani O; Hara A; Kitade Y; Matsunaga T
    J Biochem; 2015 Nov; 158(5):425-34. PubMed ID: 26002966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
    Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affinity labeling of the cofactor-binding site of estradiol 17 beta-dehydrogenase of human placenta by 5'-p-fluorosulfonylbenzoyl adenosine.
    Inano H; Tamaoki B
    J Steroid Biochem; 1985 May; 22(5):681-6. PubMed ID: 3859708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human placental 17 beta-estradiol dehydrogenase and 20 alpha-hydroxysteroid dehydrogenase. Two activities at a single enzyme active site.
    Strickler RC; Tobias B; Covey DF
    J Biol Chem; 1981 Jan; 256(1):316-21. PubMed ID: 6935192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of substituted 15β-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17β-HSD1.
    Herman BE; Kiss A; Wölfling J; Mernyák E; Szécsi M; Schneider G
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1271-1286. PubMed ID: 31307240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid dehydrogenase structures, mechanism of action, and disease.
    Duax WL; Ghosh D; Pletnev V
    Vitam Horm; 2000; 58():121-48. PubMed ID: 10668397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.